{"id":"NCT01370525","sponsor":"AstraZeneca","briefTitle":"Efficacy of Esomeprazole in Patients With Frequent Heartburn","officialTitle":"A Phase III Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of 14 Day Treatment With Esomeprazole 20 mg Once Daily in Subjects With Frequent Heartburn","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-08","primaryCompletion":"2011-10","completion":"2011-10","firstPosted":"2011-06-10","resultsPosted":"2013-03-14","lastUpdate":"2013-03-14"},"enrollment":340,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Heartburn"],"interventions":[{"type":"DRUG","name":"Esomeprazole","otherNames":[]}],"arms":[{"label":"Esomeprazole 20 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study will investigate the efficacy of esomeprazole 20 mg once a day in the treatment of frequent heartburn","primaryOutcome":{"measure":"Percentage of Heartburn Free 24 Hour Days During 14 Days of Randomized Treatment","timeFrame":"From randomisation to day 14","effectByArm":[{"arm":"Esomeprazole","deltaMin":43.32,"sd":34.36},{"arm":"Placebo","deltaMin":29.44,"sd":29.83}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":10,"countries":["United States"]},"refs":{"pmids":["31297231","29788903","27331882","25141241"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":168},"commonTop":["Nausea","Diarhhoea","Nasopharyngitis","Anaemia","Headache"]}}